Therapeutic Effects of ALT-803, an IL-15 Superagonist, in Combination with Anti-CD20 Chimeric Antigen Receptor Modified Expanded Natural Killer Cells Against Burkitt Lymphoma (BL)

Burkitt Lymphoma ◽

Antigen Receptor ◽

Therapeutic Effects ◽

Killer Cells ◽

Therapeutic Effects of ALT-803, an IL-15 Superagonist, in Combination with Anti-CD20 Chimeric Antigen Receptor Modified Expanded Natural Killer Cells Against Burkitt Lymphoma (BL)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2015.11.501 ◽

2016 ◽

Vol 22 (3) ◽

pp. S151

Author(s):

Yaya Chu ◽

Fangyu Lee ◽

Janet Ayello ◽

Brian Hang ◽

Melanie Zhang ◽

...

Keyword(s):

Natural Killer Cells ◽

Natural Killer ◽

Burkitt Lymphoma ◽

Antigen Receptor ◽

Therapeutic Effects ◽

Killer Cells ◽

Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice

OncoImmunology ◽

10.1080/2162402x.2017.1341031 ◽

2017 ◽

Vol 6 (9) ◽

pp. e1341031 ◽

Cited By ~ 18

Author(s):

Yaya Chu ◽

Ashlin Yahr ◽

Brian Huang ◽

Janet Ayello ◽

Matthew Barth ◽

...

Keyword(s):

Natural Killer Cells ◽

Natural Killer ◽

Burkitt Lymphoma ◽

Antigen Receptor ◽

Killer Cells ◽

Immunodeficient Mice ◽

Abstract 2211: Enhancedin vitroandin vivotargeting of rituximab-sensitive and -resistant Burkitt lymphoma (BL) by anti-CD20 chimeric antigen receptor (CAR)-modified expanded natural killer cells in combination with a histone deacetylase inhibitor, romidepsin

10.1158/1538-7445.am2016-2211 ◽

2016 ◽

Author(s):

Yaya Chu ◽

Ashlin Yahr ◽

Bokun Cheng ◽

Bian Hang ◽

Janet Ayello ◽

...

Keyword(s):

Natural Killer Cells ◽

Natural Killer ◽

Histone Deacetylase ◽

Burkitt Lymphoma ◽

Histone Deacetylase Inhibitor ◽

Antigen Receptor ◽

Killer Cells ◽

Deacetylase Inhibitor ◽

Therapeutic effects of a novel fusion of ALT-803, an IL-15 superagonist, with 4 single-chains of anti-CD20 antibody (2B8T2M) in combination with expanded natural killer cells against rituximab sensitive and resistant burkitt lymphoma (BL)

Cytotherapy ◽

10.1016/j.jcyt.2018.02.295 ◽

2018 ◽

Vol 20 (5) ◽

pp. S101

Author(s):

Y. Chu ◽

N. Su ◽

S. Alter ◽

E. Jeng ◽

P. Rhode ◽

...

Keyword(s):

Natural Killer Cells ◽

Natural Killer ◽

Burkitt Lymphoma ◽

Therapeutic Effects ◽

Killer Cells ◽

Cd20 Antibody ◽

Therapeutic Effects of a Novel Fusion of ALT-803, an IL-15 Superagonist, with 4 Single-Chains of Anti-CD20 Antibody (2B8T2M) in Combination with Expanded Natural Killer Cells Against Rituximab Sensitive and Resistant Burkitt Lymphoma (BL)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2017.12.659 ◽

2018 ◽

Vol 24 (3) ◽

pp. S75-S76

Author(s):

Yaya Chu ◽

Nang Kham Su ◽

Sarah Alter ◽

Emily K. Jeng ◽

Peter R. Rhode ◽

...

Keyword(s):

Natural Killer Cells ◽

Natural Killer ◽

Burkitt Lymphoma ◽

Therapeutic Effects ◽

Killer Cells ◽

Cd20 Antibody ◽

Chimeric antigen receptor-engineered natural killer cells: a promising cancer immunotherapy

Expert Review of Clinical Immunology ◽

10.1080/1744666x.2021.1911648 ◽

2021 ◽

Author(s):

Kajal Chaudhry ◽

Ehsan Dowlati ◽

Catherine M. Bollard

Keyword(s):

Natural Killer Cells ◽

Cancer Immunotherapy ◽

Natural Killer ◽

Antigen Receptor ◽

Killer Cells

Effectively Targeting Burkitt Lymphoma By Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer Cells Combined with a Histone Deacetylase Inhibitor, Romidepsin in Vitro and In Humanized NSG Mice

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2014.11.216 ◽

2015 ◽

Vol 21 (2) ◽

pp. S152-S153 ◽

Cited By ~ 2

Author(s):

Yaya Chu ◽

Ashlin Yahr ◽

Janet Ayello ◽

Mitchell S. Cairo

Keyword(s):

Natural Killer Cells ◽

Natural Killer ◽

Histone Deacetylase ◽

Burkitt Lymphoma ◽

Histone Deacetylase Inhibitor ◽

Nsg Mice ◽

Deacetylase Inhibitor ◽

Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers

Molecular Therapy ◽

10.1016/j.ymthe.2017.08.010 ◽

2017 ◽

Vol 25 (12) ◽

pp. 2607-2619 ◽

Cited By ~ 17

Author(s):

Elizabeth L. Siegler ◽

Yu Jeong Kim ◽

Xianhui Chen ◽

Natnaree Siriwon ◽

John Mac ◽

...

Keyword(s):

Natural Killer Cells ◽

Cancer Therapy ◽

Natural Killer ◽

Antigen Receptor ◽

Drug Carriers ◽

Killer Cells ◽

Combination Cancer Therapy

High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia

Frontiers in Immunology ◽

10.3389/fimmu.2019.03123 ◽

2020 ◽

Vol 10 ◽

Cited By ~ 12

Author(s):

Stephan Müller ◽

Tobias Bexte ◽

Veronika Gebel ◽

Franziska Kalensee ◽

Eva Stolzenberg ◽

...

Keyword(s):

Acute Lymphoblastic Leukemia ◽

Natural Killer Cells ◽

Natural Killer ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

Killer Cells

2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies

Journal of Hematology & Oncology ◽

10.1186/s13045-019-0732-7 ◽

2019 ◽

Vol 12 (1) ◽

Cited By ~ 17

Author(s):

Yingxi Xu ◽

Qian Liu ◽

Mengjun Zhong ◽

Zhenzhen Wang ◽

Zhaoqi Chen ◽

...

Keyword(s):

T Cell ◽

Natural Killer Cells ◽

Natural Killer ◽

Antigen Receptor ◽

Killer Cells ◽

T Cell Malignancies